{"schema_version":"secwatch.filing_event.v1","accession":"0000012208-26-000024","form_type":"8-K","ticker":"BIO","cik":"0000012208","company_name":"BIO-RAD LABORATORIES, INC.","filed_at":"2026-04-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.051210+00:00","generated_at":"2026-05-15T04:10:32.928241+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Stockholders approve Amended 2017 Incentive Award Plan, adding 335,000 shares","bullets":["Plan approved with 6.85M for, 105k against; extends expiration to March 18, 2036.","Increases share reserve by 335,000 shares for future equity grants.","Stockholder proposal on dual-class capital structure defeated (1.47M for, 5.46M against).","All six director nominees elected; KPMG ratified as auditors for FY 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0000012208-26-000024","json":"https://secwatch.observer/filing/0000012208-26-000024.json","markdown":"https://secwatch.observer/filing/0000012208-26-000024.md","text":"https://secwatch.observer/filing/0000012208-26-000024.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/12208/000001220826000024/0000012208-26-000024-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/12208/000001220826000024/bio-20260421.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T04:10:32.928241+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}